ERYTECH Reports Third Quarter 2017 Financial Results and Provides Business Update Post author:admERY Post published:November 6, 2017 Post category:Newsroom ERYTECH today provided a business update and reported its financial results for the quarter ended September 30, 2017. You Might Also Like ERYTECH Pharma receives FDA IND clearance to initiate a clinical study in Acute Lymphoblastic Leukemia in the U.S. April 3, 2013 ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event January 4, 2021 ERYTECH announces two positive DSMB reviews June 22, 2015
ERYTECH Pharma receives FDA IND clearance to initiate a clinical study in Acute Lymphoblastic Leukemia in the U.S. April 3, 2013
ERYTECH to Present at the LifeSci Partners 10th Annual Healthcare Corporate Access Event January 4, 2021
